# Crescendo Bioscience

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/crescendo-bioscience

- Industry: Biotechnology
- Headquarters: South San Francisco, US
- Website: crescendobio.com
- Total disclosed funding: $92M
- Latest round: Series D (Dec 31, 2012)
- Investors on record: 5

## About

Founded in 2002.Crescendo Bioscience is a US-based company that operates as a developer of biology-based tests for patients with autoimmune and inflammatory diseases.

## Funding rounds

- Series D, Dec 31, 2012, $28M — Kleiner Perkins, Mohr Davidow Ventures, Safeguard Scientifics, Skyline Ventures, Aeris Capital
- Series C, Jun 17, 2011, $31M — Kleiner Perkins, Mohr Davidow Ventures, Aeris Capital
- Series B, Dec 22, 2009, $13M — Kleiner Perkins, Mohr Davidow Ventures
- Series B, Jun 24, 2008, $15M — Kleiner Perkins, Mohr Davidow Ventures
- Series A, Mar 5, 2007, $5.1M — Mohr Davidow Ventures

## Investors

- Mohr Davidow Ventures (https://capitalatlas.ai/funds/mohr-davidow-ventures) — Series A, Series B, Series C, Series D
- Kleiner Perkins (https://capitalatlas.ai/funds/kleiner-perkins) — Series B, Series C, Series D
- Aeris Capital — Series C, Series D
- Safeguard Scientifics (https://capitalatlas.ai/funds/safeguard-scientifics) — Series D
- Skyline Ventures (https://capitalatlas.ai/funds/skyline-ventures) — Series D